Developer docs
API playgroundTry for free, no card

Search company profiles

Instituto Mário Penna

Full company profile

uuid000tyuk

Namestring
Instituto Mário Penna
Company typeenum
Private
Founded yearint
1971
Descriptiontext

Instituto Mário Penna is a Brazilian non-profit healthcare institution founded in 1963 and headquartered in Belo Horizonte, Minas Gerais. The organization specializes in cancer treatment, positioning it as a dedicated oncology provider within the regional health system. Its scale is substantial for a specialty non-profit, with reported headcount in the 1,001-5,000 range — indicating a multi-departmental hospital operation likely combining inpatient, outpatient, surgical, radiotherapy, chemotherapy, and diagnostic imaging capabilities typical of a comprehensive cancer center.

The institution's revenue mechanics for a Brazilian philanthropic oncology hospital typically rest on three pillars: reimbursement through the Sistema Único de Saúde (SUS, Brazil's public health system), private health-insurance and convênio billings, and donations/fundraising from individuals, corporations, and events (a common channel for entities of this type in Brazil). Pricing transparency is not disclosed in the available source material; the canonical web property (mariopenna.org.br) returned only a loader/verification page during data collection, so product mix, technology stack, partnerships, and operational details could not be verified from first-party content.

No information was available regarding recent strategic moves, leadership changes, funding rounds, capital expenditures, technology partnerships, or expansion initiatives. Given the data gap, this description is limited to verifiable firmographics; any operational or financial claims beyond founding year, location, specialty, scale, and non-profit status would be unsupported by the input.

Short descriptiontext

Instituto Mário Penna is a Brazilian non-profit oncology hospital founded in 1963 and headquartered in Belo Horizonte, providing cancer diagnosis and treatment services across the Minas Gerais region with a sizable specialty clinical workforce.

Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBelo Horizonte, Brazil
HQ citystring
Belo Horizonte
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Keyword5 values
cancer treatment services, oncology hospital care, healthcare services, cancer patient care, specialized oncology
Industry2 codes
PRIMARYHLAFAAAM
Hospital-Integrated Cancer Centers (Acute Oncology Programs)
Healthcare & Life Sciences/Healthcare Providers & Systems/Acute Care Hospitals & Health Systems
SECONDARYHLAKAEAF
Digestive Oncology (GI Cancer Care)
NAICS code1 code
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
Product category
Oncology Hospital Services
Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Instituto Mário Penna is a non-profit health institution founded in 1963 that specializes in cancer treatments. It operates as a hospital/care facility providing oncology diagnostics, treatment, and patient care services to individuals with cancer in Brazil, headquartered in Belo Horizonte.

Differentiator
Functional benefit
Problem solved
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
1Hospital Felício Rocho
TypeRegional player
Description

Large Belo Horizonte-based private hospital complex with oncology services. Comparable as a local competitor in the same city, drawing on the same patient pool and medical workforce.

TypeDirect peer
Description

One of Brazil's largest dedicated cancer hospitals based in São Paulo. Directly comparable to Instituto Mário Penna as a non-profit oncology specialty institution offering multidisciplinary cancer treatment, research, and teaching.

TypeEmerging player
Description

Network of oncology hospitals integrated into the Rede D'Or group. Comparable as a private, well-capitalized cancer care provider expanding across Brazil with stronger capex capacity.

4Hospital Israelita Albert Einstein
TypeBroad incumbent
Description

Large Brazilian private hospital system with significant oncology service lines. Comparable as a high-end hospital competitor in Minas Gerais/São Paulo corridors but broader in scope and private-pay oriented.

TypeBroad incumbent
Description

Premium Brazilian private hospital with a strong oncology program and research institute. Comparable as a high-complexity oncology provider competing for the same specialist talent and complex-case referrals.

TypeBroad incumbent
Description

Global benchmark for dedicated non-profit cancer hospitals. Comparable as a reference point for specialty cancer hospital scale, research orientation, and outcomes-driven model, though operating in a different healthcare system.

TypeRegional player
Description

Large public academic hospital affiliated with the Federal University of Minas Gerais in Belo Horizonte. Comparable as a SUS-funded, university-affiliated provider of complex oncology care in the same city.

TypeEmerging player
Description

Brazil's largest oncology clinic network, offering outpatient chemotherapy, radiotherapy, and diagnostics across multiple states. Comparable as a direct competitor for outpatient oncology volume and physician recruitment in Minas Gerais.

TypeDirect peer
Description

Major non-profit cancer hospital in Barretos, São Paulo state. Directly comparable in mission, scale, and SUS-dependent funding model, serving a large regional catchment across Brazil's oncology population.

10Hospital Santa Casa BH
TypeRegional player
Description

Historic non-profit hospital in Belo Horizonte providing oncology and complex care to SUS patients. Comparable as a fellow non-profit, SUS-dependent institution operating in the same metropolitan market.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Instituto Mário Penna

Oncology Hospital Servicesmariopenna.org.br

Instituto Mário Penna is a Brazilian non-profit oncology hospital founded in 1963 and headquartered in Belo Horizonte, providing cancer diagnosis and treatment services across the Minas Gerais region with a sizable specialty clinical workforce.

What Instituto Mário Penna does

Instituto Mário Penna is a Brazilian non-profit healthcare institution founded in 1963 and headquartered in Belo Horizonte, Minas Gerais. The organization specializes in cancer treatment, positioning it as a dedicated oncology provider within the regional health system. Its scale is substantial for a specialty non-profit, with reported headcount in the 1,001-5,000 range — indicating a multi-departmental hospital operation likely combining inpatient, outpatient, surgical, radiotherapy, chemotherapy, and diagnostic imaging capabilities typical of a comprehensive cancer center.

The institution's revenue mechanics for a Brazilian philanthropic oncology hospital typically rest on three pillars: reimbursement through the Sistema Único de Saúde (SUS, Brazil's public health system), private health-insurance and convênio billings, and donations/fundraising from individuals, corporations, and events (a common channel for entities of this type in Brazil). Pricing transparency is not disclosed in the available source material; the canonical web property (mariopenna.org.br) returned only a loader/verification page during data collection, so product mix, technology stack, partnerships, and operational details could not be verified from first-party content.

No information was available regarding recent strategic moves, leadership changes, funding rounds, capital expenditures, technology partnerships, or expansion initiatives. Given the data gap, this description is limited to verifiable firmographics; any operational or financial claims beyond founding year, location, specialty, scale, and non-profit status would be unsupported by the input.

Instituto Mário Penna firmographics

Firmographics
Name
Instituto Mário Penna
Website
https://mariopenna.org.br
Company type
Private
Founded year
1971
Headcount range
501–1,000 employees
Short description
Instituto Mário Penna is a Brazilian non-profit oncology hospital founded in 1963 and headquartered in Belo Horizonte, providing cancer diagnosis and treatment services across the Minas Gerais region with a sizable specialty clinical workforce.
Ownership category
akta.pro rank

Instituto Mário Penna industry classification

Industry
Product category
Oncology Hospital Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
akta.pro industry
PRIMARYHLAFAAAM
Hospital-Integrated Cancer Centers (Acute Oncology Programs)
Healthcare & Life Sciences/Healthcare Providers & Systems/Acute Care Hospitals & Health Systems
SECONDARYHLAKAEAF
Digestive Oncology (GI Cancer Care)

Keywords

  • Cancer treatment services
  • Oncology hospital care
  • Healthcare services
  • Cancer patient care
  • Specialized oncology

Where Instituto Mário Penna is headquartered

Location

Headquarters

HQ city
Belo Horizonte
HQ country
Brazil
HQ region
Latin America

Markets served

Instituto Mário Penna business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Instituto Mário Penna product offering

Product offering

Core offering

Instituto Mário Penna is a non-profit health institution founded in 1963 that specializes in cancer treatments. It operates as a hospital/care facility providing oncology diagnostics, treatment, and patient care services to individuals with cancer in Brazil, headquartered in Belo Horizonte.

Differentiator

Problem solved

Functional benefit

Companies that use Instituto Mário Penna

Customer profile

Ideal customer profiles1 record

Instituto Mário Penna technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Instituto Mário Penna partnerships and signals

Strategic signal

Recent moves2 records

Instituto Mário Penna competitors and assessment

Company assessment

Regional players

  • Hospital Felício Rocho: Large Belo Horizonte-based private hospital complex with oncology services. Comparable as a local competitor in the same city, drawing on the same patient pool and medical workforce.
  • Hospital das Clínicas da UFMG: Large public academic hospital affiliated with the Federal University of Minas Gerais in Belo Horizonte. Comparable as a SUS-funded, university-affiliated provider of complex oncology care in the same city.
  • Hospital Santa Casa BH: Historic non-profit hospital in Belo Horizonte providing oncology and complex care to SUS patients. Comparable as a fellow non-profit, SUS-dependent institution operating in the same metropolitan market.

Direct peers

  • A.C. Camargo Cancer Center: One of Brazil's largest dedicated cancer hospitals based in São Paulo. Directly comparable to Instituto Mário Penna as a non-profit oncology specialty institution offering multidisciplinary cancer treatment, research, and teaching.
  • Hospital de Câncer de Barretos (Fundação Pio XII): Major non-profit cancer hospital in Barretos, São Paulo state. Directly comparable in mission, scale, and SUS-dependent funding model, serving a large regional catchment across Brazil's oncology population.

Emerging players

  • Grupo Oncologia D'Or: Network of oncology hospitals integrated into the Rede D'Or group. Comparable as a private, well-capitalized cancer care provider expanding across Brazil with stronger capex capacity.
  • Oncoclínicas do Brasil: Brazil's largest oncology clinic network, offering outpatient chemotherapy, radiotherapy, and diagnostics across multiple states. Comparable as a direct competitor for outpatient oncology volume and physician recruitment in Minas Gerais.

Broad incumbents

  • Hospital Israelita Albert Einstein: Large Brazilian private hospital system with significant oncology service lines. Comparable as a high-end hospital competitor in Minas Gerais/São Paulo corridors but broader in scope and private-pay oriented.
  • Hospital Sírio-Libanês: Premium Brazilian private hospital with a strong oncology program and research institute. Comparable as a high-complexity oncology provider competing for the same specialist talent and complex-case referrals.
  • MD Anderson Cancer Center: Global benchmark for dedicated non-profit cancer hospitals. Comparable as a reference point for specialty cancer hospital scale, research orientation, and outcomes-driven model, though operating in a different healthcare system.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

Instituto Mário Penna social profiles

Digital presence

Instituto Mário Penna financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Instituto Mário Penna leadership team

Management profile

Number of profiles

Instituto Mário Penna funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Instituto Mário Penna M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto Mário Penna

What does Instituto Mário Penna do?

Instituto Mário Penna is a non-profit health institution founded in 1963 that specializes in cancer treatments. It operates as a hospital/care facility providing oncology diagnostics, treatment, and patient care services to individuals with cancer in Brazil, headquartered in Belo Horizonte.

When was Instituto Mário Penna founded?

Instituto Mário Penna was founded in 1971. It employs 501 to 1,000 people.

Where is Instituto Mário Penna based?

Instituto Mário Penna is headquartered in Belo Horizonte, Brazil, in the Latin America region.

Who are Instituto Mário Penna's main competitors?

Regional players on record are Hospital Felício Rocho, Hospital das Clínicas da UFMG and Hospital Santa Casa BH. Direct peers are A.C. Camargo Cancer Center and Hospital de Câncer de Barretos (Fundação Pio XII). Emerging players are Grupo Oncologia D'Or and Oncoclínicas do Brasil. Broad incumbents are Hospital Israelita Albert Einstein, Hospital Sírio-Libanês and MD Anderson Cancer Center.

Does Instituto Mário Penna have an API?

No public API is recorded for Instituto Mário Penna.

What industry is Instituto Mário Penna in?

Instituto Mário Penna's product category is Oncology Hospital Services. Its primary akta.pro industry code is HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs), with a secondary code of HLAKAEAF, Digestive Oncology (GI Cancer Care). Its NAICS code is 622310.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales